Dynavax (DVAX) Misses Q1 EPS by 5c

Dynavax (NASDAQ: DVAX) reported Q1 EPS of ($0.19), $0.05 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $46.92 million versus the consensus estimate of $38.58 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Keurig Dr Pepper coffee chief to depart ahead of planned split
• Winnebago Industries (WGO) PT Lowered to $40 at Benchmark on Pressured NT Demand